HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Heated, humidified high-flow nasal cannula versus nasal CPAP for respiratory support in neonates.

AbstractBACKGROUND AND OBJECTIVE:
Heated, humidified high-flow nasal cannula (HHHFNC) is commonly used as a noninvasive mode of respiratory support in the NICU. The safety and efficacy of HHHFNC have not been compared with other modes of noninvasive support in large randomized trials. The objective was to assess the efficacy and safety of HHHFNC compared with nasal continuous positive airway pressure (nCPAP) for noninvasive respiratory support in the NICU.
METHODS:
Randomized, controlled, unblinded noncrossover trial in 432 infants ranging from 28 to 42 weeks' gestational age with planned nCPAP support, as either primary therapy or postextubation. The primary outcome was defined as a need for intubation within 72 hours of applied noninvasive therapy.
RESULTS:
There was no difference in early failure for HHHFNC (23/212 [10.8%]) versus nCPAP (18/220 [8.2%]; P = .344), subsequent need for any intubation (32/212 [15.1%] vs 25/220 [11.4%]; P = .252), or in any of several adverse outcomes analyzed, including air leak. HHHFNC infants remained on the study mode significantly longer than nCPAP infants (median: 4 vs 2 days, respectively; P < .01), but there were no differences between study groups for days on supplemental oxygen (median: 10 vs 8 days), bronchopulmonary dysplasia (20% vs 16%), or discharge from the hospital on oxygen (19% vs 18%).
CONCLUSIONS:
Among infants ≥28 weeks' gestational age, HHHFNC appears to have similar efficacy and safety to nCPAP when applied immediately postextubation or early as initial noninvasive support for respiratory dysfunction.
AuthorsBradley A Yoder, Ronald A Stoddard, Ma Li, Jerald King, Daniel R Dirnberger, Soraya Abbasi
JournalPediatrics (Pediatrics) Vol. 131 Issue 5 Pg. e1482-90 (May 2013) ISSN: 1098-4275 [Electronic] United States
PMID23610207 (Publication Type: Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial)
Chemical References
  • Oxygen
Topics
  • Catheterization
  • Catheterization, Peripheral (instrumentation, methods)
  • Continuous Positive Airway Pressure (instrumentation, methods)
  • Female
  • Follow-Up Studies
  • Gestational Age
  • Hospital Mortality (trends)
  • Hot Temperature (therapeutic use)
  • Humans
  • Infant, Newborn
  • Infant, Premature
  • Intensive Care Units, Neonatal
  • Intermittent Positive-Pressure Ventilation (instrumentation, methods)
  • Male
  • Noninvasive Ventilation (methods, mortality)
  • Oxygen (therapeutic use)
  • Pregnancy
  • Prospective Studies
  • Respiratory Distress Syndrome, Newborn (diagnosis, mortality, therapy)
  • Risk Assessment
  • Statistics, Nonparametric
  • Survival Rate
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: